STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended		27 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Apr. 14, 2020	Jun. 30, 2022	Jun. 30, 2021	Oct. 04, 2021	Oct. 02, 2021	May 10, 2021	Jun. 30, 2020
Subsidiary, Sale of Stock [Line Items]
Income tax net				$ 0	$ 0
Stock based compensation expense		$ 20,000		$ 915,494	$ 733,930
Stock issued new, shares			200,000			2,500,000	937,500
2020 April Stock Sale [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued new, shares			200,000
Proceeds from issuance of common stock			$ 250,000
October 2021 Sale [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued new, shares						2,500,000	937,500
Proceeds from issuance of common stock						$ 4,000,000
Plan 2022 [Member]
Subsidiary, Sale of Stock [Line Items]
Shares authorized for issuance under the plan				1,000,000
2021 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Shares authorized for issuance under the plan								1,000,000
Shares available for future grants				206,403	1,000,000
Stock options outstanding				784,502
2011 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding				1,884,800
2006 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding				44,698
Chief Financial Officer [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued	9,095
Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Unrecognized compensation costs related to options vesting				$ 534,653
Options granted				614,500	630,000
Stock options outstanding				2,714,000	2,578,200				2,065,200
Aggregate intrinsic value of "in the money" outstanding				$ 1,844,170
Aggregate intrinsic value of "in the money" exercisable				$ 1,779,345